Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Zvi Steinberg who wrote (1148)	8/19/1998 2:11:00 PM
From: yosi s	of 1491

I think that the summary of PARS is very bullish. 1. Enough cash to last to 1st Q 99. no need to raise more money, no further dilution.etc 2. Sales of lotemax and Alrex growing. 3. as of 1 year from now Lotemax T should start to add to revenues, Boosting it by 100%, And since expenses pretty much remains fix, direct increase in profitability is huge. This will also give PARS enough money to finance its portion of HU211. great news. 4. not included are European sales. And once Tobra Lotemax is in US expect it to go to Europe. 5. HU211 partner to join once results are in. well if unblinding is very + I expect partner to come in and start planning. The longer a partner waits and the study progresses, well will Pars be able to get better terms. 6. I am sure a lot of pressure is on to have news release by annual meetings. 7. BOL better get rolling with announcement of partner. anthing about terms and upfront payment. 8. I am sure that once results of HU211 are out and partner give legitamacy to phase 3 study many analyst will jump in. causing a flurry of exposure and the stock will finally move. the longer it takes the higher it will go.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next